Baidu
map
REPROD SCI 润色咨询

Reproductive Sciences

出版年份:2007 年文章数:2253 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:11.3% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2223836, encodeId=105b222383613, content=8.22投稿,到现在一直是Editor Assigned,这是要被拒吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c3b9416313, createdName=ms2000000922500034, createdTime=Tue Sep 03 13:40:14 CST 2024, time=2024-09-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=508154, encodeId=e980508154ad, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:审稿速度快,意见中肯,我是刚好1个月审稿,要求小修,认真回复后,1个周后接受。本人第一篇SCI,颇感兴奋,愿大家一起进步!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31b3107545, createdName=lzt1988, createdTime=Thu Dec 04 19:07:00 CST 2014, time=2014-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212786, encodeId=395f2212e86c9, content=偏重的研究方向:生殖医学<br>经验分享:2024.1.27投稿,两天立即送审了,中间找了2.3个月审稿人哈哈哈,5.20一审意见返回,大修,修了10天左右送回去了,6.25接收,第二篇sci,共勉!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66548632914, createdName=ms4000000480569699, createdTime=Tue Jul 02 14:33:27 CST 2024, time=2024-07-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=998056, encodeId=d8f0998056a3, content=2020年10月31号投稿,2021年1月14日返修,2月25日修回,2月27日显示送外审,到现在状态也没变化,时间也没变化,有没有类似情况的朋友?已经4个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ceb5420687, createdName=ms6000001352468085, createdTime=Fri Jul 09 20:11:44 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205846, encodeId=869e1205846dc, content=请问大家irb approval怎么搞的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/GVenxYicdvic8y0S8u0eCicFMiaY4MhYKianWnHAOEhmrUuIG95l4TY9VHliaG0SHOtNeXQia1WYGhhYMSzHcDlaz4WBA/132, createdBy=e3105157968, createdName=pmzhangjie, createdTime=Fri Mar 25 13:42:05 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2168342, encodeId=0a6c2168342a4, content=审稿速度:1.0<br>偏重的研究方向:生殖医学<br>经验分享:有大佬知道 Change authorship form在哪儿嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2c38649666, createdName=ms7000000322607475, createdTime=Mon Nov 13 21:54:09 CST 2023, time=2023-11-13, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1083380, encodeId=813c108338041, content=偏重的研究方向:生物信息学;围产医学;生殖医学<br>经验分享:请问上传伦理审查的文件在哪里找,提交需要IRB approval,是自己写完找单位盖章吗,求各位大神 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=996d5652385, createdName=ms3000002068420902, createdTime=Thu Dec 23 00:22:15 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569900, encodeId=32645699002b, content=online快一年了,还没有正式出版没有卷和期号无法进行文献检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/848cb2649bb2ba3563871a6dd0e8c5e7.jpg, createdBy=45362264868, createdName=打豆豆d d d, createdTime=Mon Apr 22 00:00:00 CST 2019, time=2019-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222142, encodeId=0089122214274, content=大修返修回去之后一直是Editor Assigned状态,有人知道什么意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/01/5ff3f1f23a551b430a9b118ce34c50e5.jpg, createdBy=fe362272136, createdName=Coolina-, createdTime=Tue May 24 19:32:08 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209829, encodeId=a66f120982933, content=大家的参考文献格式用的哪种哇?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50e56410073, createdName=ms7000000685176097, createdTime=Sat Apr 09 16:13:55 CST 2022, time=2022-04-09, status=1, ipAttribution=)]
    2024-09-03 ms2000000922500034 来自山东省

    8.22投稿,到现在一直是Editor Assigned,这是要被拒吗

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2223836, encodeId=105b222383613, content=8.22投稿,到现在一直是Editor Assigned,这是要被拒吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c3b9416313, createdName=ms2000000922500034, createdTime=Tue Sep 03 13:40:14 CST 2024, time=2024-09-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=508154, encodeId=e980508154ad, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:审稿速度快,意见中肯,我是刚好1个月审稿,要求小修,认真回复后,1个周后接受。本人第一篇SCI,颇感兴奋,愿大家一起进步!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31b3107545, createdName=lzt1988, createdTime=Thu Dec 04 19:07:00 CST 2014, time=2014-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212786, encodeId=395f2212e86c9, content=偏重的研究方向:生殖医学<br>经验分享:2024.1.27投稿,两天立即送审了,中间找了2.3个月审稿人哈哈哈,5.20一审意见返回,大修,修了10天左右送回去了,6.25接收,第二篇sci,共勉!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66548632914, createdName=ms4000000480569699, createdTime=Tue Jul 02 14:33:27 CST 2024, time=2024-07-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=998056, encodeId=d8f0998056a3, content=2020年10月31号投稿,2021年1月14日返修,2月25日修回,2月27日显示送外审,到现在状态也没变化,时间也没变化,有没有类似情况的朋友?已经4个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ceb5420687, createdName=ms6000001352468085, createdTime=Fri Jul 09 20:11:44 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205846, encodeId=869e1205846dc, content=请问大家irb approval怎么搞的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/GVenxYicdvic8y0S8u0eCicFMiaY4MhYKianWnHAOEhmrUuIG95l4TY9VHliaG0SHOtNeXQia1WYGhhYMSzHcDlaz4WBA/132, createdBy=e3105157968, createdName=pmzhangjie, createdTime=Fri Mar 25 13:42:05 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2168342, encodeId=0a6c2168342a4, content=审稿速度:1.0<br>偏重的研究方向:生殖医学<br>经验分享:有大佬知道 Change authorship form在哪儿嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2c38649666, createdName=ms7000000322607475, createdTime=Mon Nov 13 21:54:09 CST 2023, time=2023-11-13, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1083380, encodeId=813c108338041, content=偏重的研究方向:生物信息学;围产医学;生殖医学<br>经验分享:请问上传伦理审查的文件在哪里找,提交需要IRB approval,是自己写完找单位盖章吗,求各位大神 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=996d5652385, createdName=ms3000002068420902, createdTime=Thu Dec 23 00:22:15 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569900, encodeId=32645699002b, content=online快一年了,还没有正式出版没有卷和期号无法进行文献检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/848cb2649bb2ba3563871a6dd0e8c5e7.jpg, createdBy=45362264868, createdName=打豆豆d d d, createdTime=Mon Apr 22 00:00:00 CST 2019, time=2019-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222142, encodeId=0089122214274, content=大修返修回去之后一直是Editor Assigned状态,有人知道什么意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/01/5ff3f1f23a551b430a9b118ce34c50e5.jpg, createdBy=fe362272136, createdName=Coolina-, createdTime=Tue May 24 19:32:08 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209829, encodeId=a66f120982933, content=大家的参考文献格式用的哪种哇?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50e56410073, createdName=ms7000000685176097, createdTime=Sat Apr 09 16:13:55 CST 2022, time=2022-04-09, status=1, ipAttribution=)]
    2014-12-04 lzt1988

    审稿速度:1.0 | 投稿命中率:50.0
    经验分享:审稿速度快,意见中肯,我是刚好1个月审稿,要求小修,认真回复后,1个周后接受。本人第一篇SCI,颇感兴奋,愿大家一起进步!

    6

    展开6条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2223836, encodeId=105b222383613, content=8.22投稿,到现在一直是Editor Assigned,这是要被拒吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c3b9416313, createdName=ms2000000922500034, createdTime=Tue Sep 03 13:40:14 CST 2024, time=2024-09-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=508154, encodeId=e980508154ad, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:审稿速度快,意见中肯,我是刚好1个月审稿,要求小修,认真回复后,1个周后接受。本人第一篇SCI,颇感兴奋,愿大家一起进步!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31b3107545, createdName=lzt1988, createdTime=Thu Dec 04 19:07:00 CST 2014, time=2014-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212786, encodeId=395f2212e86c9, content=偏重的研究方向:生殖医学<br>经验分享:2024.1.27投稿,两天立即送审了,中间找了2.3个月审稿人哈哈哈,5.20一审意见返回,大修,修了10天左右送回去了,6.25接收,第二篇sci,共勉!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66548632914, createdName=ms4000000480569699, createdTime=Tue Jul 02 14:33:27 CST 2024, time=2024-07-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=998056, encodeId=d8f0998056a3, content=2020年10月31号投稿,2021年1月14日返修,2月25日修回,2月27日显示送外审,到现在状态也没变化,时间也没变化,有没有类似情况的朋友?已经4个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ceb5420687, createdName=ms6000001352468085, createdTime=Fri Jul 09 20:11:44 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205846, encodeId=869e1205846dc, content=请问大家irb approval怎么搞的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/GVenxYicdvic8y0S8u0eCicFMiaY4MhYKianWnHAOEhmrUuIG95l4TY9VHliaG0SHOtNeXQia1WYGhhYMSzHcDlaz4WBA/132, createdBy=e3105157968, createdName=pmzhangjie, createdTime=Fri Mar 25 13:42:05 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2168342, encodeId=0a6c2168342a4, content=审稿速度:1.0<br>偏重的研究方向:生殖医学<br>经验分享:有大佬知道 Change authorship form在哪儿嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2c38649666, createdName=ms7000000322607475, createdTime=Mon Nov 13 21:54:09 CST 2023, time=2023-11-13, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1083380, encodeId=813c108338041, content=偏重的研究方向:生物信息学;围产医学;生殖医学<br>经验分享:请问上传伦理审查的文件在哪里找,提交需要IRB approval,是自己写完找单位盖章吗,求各位大神 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=996d5652385, createdName=ms3000002068420902, createdTime=Thu Dec 23 00:22:15 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569900, encodeId=32645699002b, content=online快一年了,还没有正式出版没有卷和期号无法进行文献检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/848cb2649bb2ba3563871a6dd0e8c5e7.jpg, createdBy=45362264868, createdName=打豆豆d d d, createdTime=Mon Apr 22 00:00:00 CST 2019, time=2019-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222142, encodeId=0089122214274, content=大修返修回去之后一直是Editor Assigned状态,有人知道什么意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/01/5ff3f1f23a551b430a9b118ce34c50e5.jpg, createdBy=fe362272136, createdName=Coolina-, createdTime=Tue May 24 19:32:08 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209829, encodeId=a66f120982933, content=大家的参考文献格式用的哪种哇?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50e56410073, createdName=ms7000000685176097, createdTime=Sat Apr 09 16:13:55 CST 2022, time=2022-04-09, status=1, ipAttribution=)]
    2024-07-02 ms4000000480569699 来自陕西省

    偏重的研究方向:生殖医学
    经验分享:2024.1.27投稿,两天立即送审了,中间找了2.3个月审稿人哈哈哈,5.20一审意见返回,大修,修了10天左右送回去了,6.25接收,第二篇sci,共勉!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2223836, encodeId=105b222383613, content=8.22投稿,到现在一直是Editor Assigned,这是要被拒吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c3b9416313, createdName=ms2000000922500034, createdTime=Tue Sep 03 13:40:14 CST 2024, time=2024-09-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=508154, encodeId=e980508154ad, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:审稿速度快,意见中肯,我是刚好1个月审稿,要求小修,认真回复后,1个周后接受。本人第一篇SCI,颇感兴奋,愿大家一起进步!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31b3107545, createdName=lzt1988, createdTime=Thu Dec 04 19:07:00 CST 2014, time=2014-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212786, encodeId=395f2212e86c9, content=偏重的研究方向:生殖医学<br>经验分享:2024.1.27投稿,两天立即送审了,中间找了2.3个月审稿人哈哈哈,5.20一审意见返回,大修,修了10天左右送回去了,6.25接收,第二篇sci,共勉!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66548632914, createdName=ms4000000480569699, createdTime=Tue Jul 02 14:33:27 CST 2024, time=2024-07-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=998056, encodeId=d8f0998056a3, content=2020年10月31号投稿,2021年1月14日返修,2月25日修回,2月27日显示送外审,到现在状态也没变化,时间也没变化,有没有类似情况的朋友?已经4个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ceb5420687, createdName=ms6000001352468085, createdTime=Fri Jul 09 20:11:44 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205846, encodeId=869e1205846dc, content=请问大家irb approval怎么搞的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/GVenxYicdvic8y0S8u0eCicFMiaY4MhYKianWnHAOEhmrUuIG95l4TY9VHliaG0SHOtNeXQia1WYGhhYMSzHcDlaz4WBA/132, createdBy=e3105157968, createdName=pmzhangjie, createdTime=Fri Mar 25 13:42:05 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2168342, encodeId=0a6c2168342a4, content=审稿速度:1.0<br>偏重的研究方向:生殖医学<br>经验分享:有大佬知道 Change authorship form在哪儿嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2c38649666, createdName=ms7000000322607475, createdTime=Mon Nov 13 21:54:09 CST 2023, time=2023-11-13, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1083380, encodeId=813c108338041, content=偏重的研究方向:生物信息学;围产医学;生殖医学<br>经验分享:请问上传伦理审查的文件在哪里找,提交需要IRB approval,是自己写完找单位盖章吗,求各位大神 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=996d5652385, createdName=ms3000002068420902, createdTime=Thu Dec 23 00:22:15 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569900, encodeId=32645699002b, content=online快一年了,还没有正式出版没有卷和期号无法进行文献检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/848cb2649bb2ba3563871a6dd0e8c5e7.jpg, createdBy=45362264868, createdName=打豆豆d d d, createdTime=Mon Apr 22 00:00:00 CST 2019, time=2019-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222142, encodeId=0089122214274, content=大修返修回去之后一直是Editor Assigned状态,有人知道什么意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/01/5ff3f1f23a551b430a9b118ce34c50e5.jpg, createdBy=fe362272136, createdName=Coolina-, createdTime=Tue May 24 19:32:08 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209829, encodeId=a66f120982933, content=大家的参考文献格式用的哪种哇?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50e56410073, createdName=ms7000000685176097, createdTime=Sat Apr 09 16:13:55 CST 2022, time=2022-04-09, status=1, ipAttribution=)]
    2021-07-09 ms6000001352468085

    2020年10月31号投稿,2021年1月14日返修,2月25日修回,2月27日显示送外审,到现在状态也没变化,时间也没变化,有没有类似情况的朋友?已经4个多月了

    7

    展开7条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2223836, encodeId=105b222383613, content=8.22投稿,到现在一直是Editor Assigned,这是要被拒吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c3b9416313, createdName=ms2000000922500034, createdTime=Tue Sep 03 13:40:14 CST 2024, time=2024-09-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=508154, encodeId=e980508154ad, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:审稿速度快,意见中肯,我是刚好1个月审稿,要求小修,认真回复后,1个周后接受。本人第一篇SCI,颇感兴奋,愿大家一起进步!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31b3107545, createdName=lzt1988, createdTime=Thu Dec 04 19:07:00 CST 2014, time=2014-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212786, encodeId=395f2212e86c9, content=偏重的研究方向:生殖医学<br>经验分享:2024.1.27投稿,两天立即送审了,中间找了2.3个月审稿人哈哈哈,5.20一审意见返回,大修,修了10天左右送回去了,6.25接收,第二篇sci,共勉!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66548632914, createdName=ms4000000480569699, createdTime=Tue Jul 02 14:33:27 CST 2024, time=2024-07-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=998056, encodeId=d8f0998056a3, content=2020年10月31号投稿,2021年1月14日返修,2月25日修回,2月27日显示送外审,到现在状态也没变化,时间也没变化,有没有类似情况的朋友?已经4个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ceb5420687, createdName=ms6000001352468085, createdTime=Fri Jul 09 20:11:44 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205846, encodeId=869e1205846dc, content=请问大家irb approval怎么搞的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/GVenxYicdvic8y0S8u0eCicFMiaY4MhYKianWnHAOEhmrUuIG95l4TY9VHliaG0SHOtNeXQia1WYGhhYMSzHcDlaz4WBA/132, createdBy=e3105157968, createdName=pmzhangjie, createdTime=Fri Mar 25 13:42:05 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2168342, encodeId=0a6c2168342a4, content=审稿速度:1.0<br>偏重的研究方向:生殖医学<br>经验分享:有大佬知道 Change authorship form在哪儿嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2c38649666, createdName=ms7000000322607475, createdTime=Mon Nov 13 21:54:09 CST 2023, time=2023-11-13, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1083380, encodeId=813c108338041, content=偏重的研究方向:生物信息学;围产医学;生殖医学<br>经验分享:请问上传伦理审查的文件在哪里找,提交需要IRB approval,是自己写完找单位盖章吗,求各位大神 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=996d5652385, createdName=ms3000002068420902, createdTime=Thu Dec 23 00:22:15 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569900, encodeId=32645699002b, content=online快一年了,还没有正式出版没有卷和期号无法进行文献检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/848cb2649bb2ba3563871a6dd0e8c5e7.jpg, createdBy=45362264868, createdName=打豆豆d d d, createdTime=Mon Apr 22 00:00:00 CST 2019, time=2019-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222142, encodeId=0089122214274, content=大修返修回去之后一直是Editor Assigned状态,有人知道什么意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/01/5ff3f1f23a551b430a9b118ce34c50e5.jpg, createdBy=fe362272136, createdName=Coolina-, createdTime=Tue May 24 19:32:08 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209829, encodeId=a66f120982933, content=大家的参考文献格式用的哪种哇?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50e56410073, createdName=ms7000000685176097, createdTime=Sat Apr 09 16:13:55 CST 2022, time=2022-04-09, status=1, ipAttribution=)]
    2022-03-25 pmzhangjie

    请问大家irb approval怎么搞的啊

    9

    展开9条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2223836, encodeId=105b222383613, content=8.22投稿,到现在一直是Editor Assigned,这是要被拒吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c3b9416313, createdName=ms2000000922500034, createdTime=Tue Sep 03 13:40:14 CST 2024, time=2024-09-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=508154, encodeId=e980508154ad, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:审稿速度快,意见中肯,我是刚好1个月审稿,要求小修,认真回复后,1个周后接受。本人第一篇SCI,颇感兴奋,愿大家一起进步!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31b3107545, createdName=lzt1988, createdTime=Thu Dec 04 19:07:00 CST 2014, time=2014-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212786, encodeId=395f2212e86c9, content=偏重的研究方向:生殖医学<br>经验分享:2024.1.27投稿,两天立即送审了,中间找了2.3个月审稿人哈哈哈,5.20一审意见返回,大修,修了10天左右送回去了,6.25接收,第二篇sci,共勉!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66548632914, createdName=ms4000000480569699, createdTime=Tue Jul 02 14:33:27 CST 2024, time=2024-07-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=998056, encodeId=d8f0998056a3, content=2020年10月31号投稿,2021年1月14日返修,2月25日修回,2月27日显示送外审,到现在状态也没变化,时间也没变化,有没有类似情况的朋友?已经4个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ceb5420687, createdName=ms6000001352468085, createdTime=Fri Jul 09 20:11:44 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205846, encodeId=869e1205846dc, content=请问大家irb approval怎么搞的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/GVenxYicdvic8y0S8u0eCicFMiaY4MhYKianWnHAOEhmrUuIG95l4TY9VHliaG0SHOtNeXQia1WYGhhYMSzHcDlaz4WBA/132, createdBy=e3105157968, createdName=pmzhangjie, createdTime=Fri Mar 25 13:42:05 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2168342, encodeId=0a6c2168342a4, content=审稿速度:1.0<br>偏重的研究方向:生殖医学<br>经验分享:有大佬知道 Change authorship form在哪儿嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2c38649666, createdName=ms7000000322607475, createdTime=Mon Nov 13 21:54:09 CST 2023, time=2023-11-13, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1083380, encodeId=813c108338041, content=偏重的研究方向:生物信息学;围产医学;生殖医学<br>经验分享:请问上传伦理审查的文件在哪里找,提交需要IRB approval,是自己写完找单位盖章吗,求各位大神 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=996d5652385, createdName=ms3000002068420902, createdTime=Thu Dec 23 00:22:15 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569900, encodeId=32645699002b, content=online快一年了,还没有正式出版没有卷和期号无法进行文献检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/848cb2649bb2ba3563871a6dd0e8c5e7.jpg, createdBy=45362264868, createdName=打豆豆d d d, createdTime=Mon Apr 22 00:00:00 CST 2019, time=2019-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222142, encodeId=0089122214274, content=大修返修回去之后一直是Editor Assigned状态,有人知道什么意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/01/5ff3f1f23a551b430a9b118ce34c50e5.jpg, createdBy=fe362272136, createdName=Coolina-, createdTime=Tue May 24 19:32:08 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209829, encodeId=a66f120982933, content=大家的参考文献格式用的哪种哇?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50e56410073, createdName=ms7000000685176097, createdTime=Sat Apr 09 16:13:55 CST 2022, time=2022-04-09, status=1, ipAttribution=)]
    2023-11-13 ms7000000322607475 来自甘肃省

    审稿速度:1.0
    偏重的研究方向:生殖医学
    经验分享:有大佬知道 Change authorship form在哪儿嘛?

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2223836, encodeId=105b222383613, content=8.22投稿,到现在一直是Editor Assigned,这是要被拒吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c3b9416313, createdName=ms2000000922500034, createdTime=Tue Sep 03 13:40:14 CST 2024, time=2024-09-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=508154, encodeId=e980508154ad, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:审稿速度快,意见中肯,我是刚好1个月审稿,要求小修,认真回复后,1个周后接受。本人第一篇SCI,颇感兴奋,愿大家一起进步!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31b3107545, createdName=lzt1988, createdTime=Thu Dec 04 19:07:00 CST 2014, time=2014-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212786, encodeId=395f2212e86c9, content=偏重的研究方向:生殖医学<br>经验分享:2024.1.27投稿,两天立即送审了,中间找了2.3个月审稿人哈哈哈,5.20一审意见返回,大修,修了10天左右送回去了,6.25接收,第二篇sci,共勉!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66548632914, createdName=ms4000000480569699, createdTime=Tue Jul 02 14:33:27 CST 2024, time=2024-07-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=998056, encodeId=d8f0998056a3, content=2020年10月31号投稿,2021年1月14日返修,2月25日修回,2月27日显示送外审,到现在状态也没变化,时间也没变化,有没有类似情况的朋友?已经4个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ceb5420687, createdName=ms6000001352468085, createdTime=Fri Jul 09 20:11:44 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205846, encodeId=869e1205846dc, content=请问大家irb approval怎么搞的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/GVenxYicdvic8y0S8u0eCicFMiaY4MhYKianWnHAOEhmrUuIG95l4TY9VHliaG0SHOtNeXQia1WYGhhYMSzHcDlaz4WBA/132, createdBy=e3105157968, createdName=pmzhangjie, createdTime=Fri Mar 25 13:42:05 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2168342, encodeId=0a6c2168342a4, content=审稿速度:1.0<br>偏重的研究方向:生殖医学<br>经验分享:有大佬知道 Change authorship form在哪儿嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2c38649666, createdName=ms7000000322607475, createdTime=Mon Nov 13 21:54:09 CST 2023, time=2023-11-13, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1083380, encodeId=813c108338041, content=偏重的研究方向:生物信息学;围产医学;生殖医学<br>经验分享:请问上传伦理审查的文件在哪里找,提交需要IRB approval,是自己写完找单位盖章吗,求各位大神 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=996d5652385, createdName=ms3000002068420902, createdTime=Thu Dec 23 00:22:15 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569900, encodeId=32645699002b, content=online快一年了,还没有正式出版没有卷和期号无法进行文献检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/848cb2649bb2ba3563871a6dd0e8c5e7.jpg, createdBy=45362264868, createdName=打豆豆d d d, createdTime=Mon Apr 22 00:00:00 CST 2019, time=2019-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222142, encodeId=0089122214274, content=大修返修回去之后一直是Editor Assigned状态,有人知道什么意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/01/5ff3f1f23a551b430a9b118ce34c50e5.jpg, createdBy=fe362272136, createdName=Coolina-, createdTime=Tue May 24 19:32:08 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209829, encodeId=a66f120982933, content=大家的参考文献格式用的哪种哇?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50e56410073, createdName=ms7000000685176097, createdTime=Sat Apr 09 16:13:55 CST 2022, time=2022-04-09, status=1, ipAttribution=)]
    2021-12-23 ms3000002068420902

    偏重的研究方向:生物信息学;围产医学;生殖医学
    经验分享:请问上传伦理审查的文件在哪里找,提交需要IRB approval,是自己写完找单位盖章吗,求各位大神

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2223836, encodeId=105b222383613, content=8.22投稿,到现在一直是Editor Assigned,这是要被拒吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c3b9416313, createdName=ms2000000922500034, createdTime=Tue Sep 03 13:40:14 CST 2024, time=2024-09-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=508154, encodeId=e980508154ad, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:审稿速度快,意见中肯,我是刚好1个月审稿,要求小修,认真回复后,1个周后接受。本人第一篇SCI,颇感兴奋,愿大家一起进步!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31b3107545, createdName=lzt1988, createdTime=Thu Dec 04 19:07:00 CST 2014, time=2014-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212786, encodeId=395f2212e86c9, content=偏重的研究方向:生殖医学<br>经验分享:2024.1.27投稿,两天立即送审了,中间找了2.3个月审稿人哈哈哈,5.20一审意见返回,大修,修了10天左右送回去了,6.25接收,第二篇sci,共勉!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66548632914, createdName=ms4000000480569699, createdTime=Tue Jul 02 14:33:27 CST 2024, time=2024-07-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=998056, encodeId=d8f0998056a3, content=2020年10月31号投稿,2021年1月14日返修,2月25日修回,2月27日显示送外审,到现在状态也没变化,时间也没变化,有没有类似情况的朋友?已经4个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ceb5420687, createdName=ms6000001352468085, createdTime=Fri Jul 09 20:11:44 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205846, encodeId=869e1205846dc, content=请问大家irb approval怎么搞的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/GVenxYicdvic8y0S8u0eCicFMiaY4MhYKianWnHAOEhmrUuIG95l4TY9VHliaG0SHOtNeXQia1WYGhhYMSzHcDlaz4WBA/132, createdBy=e3105157968, createdName=pmzhangjie, createdTime=Fri Mar 25 13:42:05 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2168342, encodeId=0a6c2168342a4, content=审稿速度:1.0<br>偏重的研究方向:生殖医学<br>经验分享:有大佬知道 Change authorship form在哪儿嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2c38649666, createdName=ms7000000322607475, createdTime=Mon Nov 13 21:54:09 CST 2023, time=2023-11-13, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1083380, encodeId=813c108338041, content=偏重的研究方向:生物信息学;围产医学;生殖医学<br>经验分享:请问上传伦理审查的文件在哪里找,提交需要IRB approval,是自己写完找单位盖章吗,求各位大神 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=996d5652385, createdName=ms3000002068420902, createdTime=Thu Dec 23 00:22:15 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569900, encodeId=32645699002b, content=online快一年了,还没有正式出版没有卷和期号无法进行文献检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/848cb2649bb2ba3563871a6dd0e8c5e7.jpg, createdBy=45362264868, createdName=打豆豆d d d, createdTime=Mon Apr 22 00:00:00 CST 2019, time=2019-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222142, encodeId=0089122214274, content=大修返修回去之后一直是Editor Assigned状态,有人知道什么意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/01/5ff3f1f23a551b430a9b118ce34c50e5.jpg, createdBy=fe362272136, createdName=Coolina-, createdTime=Tue May 24 19:32:08 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209829, encodeId=a66f120982933, content=大家的参考文献格式用的哪种哇?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50e56410073, createdName=ms7000000685176097, createdTime=Sat Apr 09 16:13:55 CST 2022, time=2022-04-09, status=1, ipAttribution=)]
    2019-04-22 打豆豆d d d

    online快一年了,还没有正式出版没有卷和期号无法进行文献检索啊

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2223836, encodeId=105b222383613, content=8.22投稿,到现在一直是Editor Assigned,这是要被拒吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c3b9416313, createdName=ms2000000922500034, createdTime=Tue Sep 03 13:40:14 CST 2024, time=2024-09-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=508154, encodeId=e980508154ad, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:审稿速度快,意见中肯,我是刚好1个月审稿,要求小修,认真回复后,1个周后接受。本人第一篇SCI,颇感兴奋,愿大家一起进步!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31b3107545, createdName=lzt1988, createdTime=Thu Dec 04 19:07:00 CST 2014, time=2014-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212786, encodeId=395f2212e86c9, content=偏重的研究方向:生殖医学<br>经验分享:2024.1.27投稿,两天立即送审了,中间找了2.3个月审稿人哈哈哈,5.20一审意见返回,大修,修了10天左右送回去了,6.25接收,第二篇sci,共勉!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66548632914, createdName=ms4000000480569699, createdTime=Tue Jul 02 14:33:27 CST 2024, time=2024-07-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=998056, encodeId=d8f0998056a3, content=2020年10月31号投稿,2021年1月14日返修,2月25日修回,2月27日显示送外审,到现在状态也没变化,时间也没变化,有没有类似情况的朋友?已经4个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ceb5420687, createdName=ms6000001352468085, createdTime=Fri Jul 09 20:11:44 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205846, encodeId=869e1205846dc, content=请问大家irb approval怎么搞的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/GVenxYicdvic8y0S8u0eCicFMiaY4MhYKianWnHAOEhmrUuIG95l4TY9VHliaG0SHOtNeXQia1WYGhhYMSzHcDlaz4WBA/132, createdBy=e3105157968, createdName=pmzhangjie, createdTime=Fri Mar 25 13:42:05 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2168342, encodeId=0a6c2168342a4, content=审稿速度:1.0<br>偏重的研究方向:生殖医学<br>经验分享:有大佬知道 Change authorship form在哪儿嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2c38649666, createdName=ms7000000322607475, createdTime=Mon Nov 13 21:54:09 CST 2023, time=2023-11-13, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1083380, encodeId=813c108338041, content=偏重的研究方向:生物信息学;围产医学;生殖医学<br>经验分享:请问上传伦理审查的文件在哪里找,提交需要IRB approval,是自己写完找单位盖章吗,求各位大神 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=996d5652385, createdName=ms3000002068420902, createdTime=Thu Dec 23 00:22:15 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569900, encodeId=32645699002b, content=online快一年了,还没有正式出版没有卷和期号无法进行文献检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/848cb2649bb2ba3563871a6dd0e8c5e7.jpg, createdBy=45362264868, createdName=打豆豆d d d, createdTime=Mon Apr 22 00:00:00 CST 2019, time=2019-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222142, encodeId=0089122214274, content=大修返修回去之后一直是Editor Assigned状态,有人知道什么意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/01/5ff3f1f23a551b430a9b118ce34c50e5.jpg, createdBy=fe362272136, createdName=Coolina-, createdTime=Tue May 24 19:32:08 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209829, encodeId=a66f120982933, content=大家的参考文献格式用的哪种哇?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50e56410073, createdName=ms7000000685176097, createdTime=Sat Apr 09 16:13:55 CST 2022, time=2022-04-09, status=1, ipAttribution=)]
    2022-05-24 Coolina-

    大修返修回去之后一直是Editor Assigned状态,有人知道什么意思吗

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2223836, encodeId=105b222383613, content=8.22投稿,到现在一直是Editor Assigned,这是要被拒吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c3b9416313, createdName=ms2000000922500034, createdTime=Tue Sep 03 13:40:14 CST 2024, time=2024-09-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=508154, encodeId=e980508154ad, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:审稿速度快,意见中肯,我是刚好1个月审稿,要求小修,认真回复后,1个周后接受。本人第一篇SCI,颇感兴奋,愿大家一起进步!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31b3107545, createdName=lzt1988, createdTime=Thu Dec 04 19:07:00 CST 2014, time=2014-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212786, encodeId=395f2212e86c9, content=偏重的研究方向:生殖医学<br>经验分享:2024.1.27投稿,两天立即送审了,中间找了2.3个月审稿人哈哈哈,5.20一审意见返回,大修,修了10天左右送回去了,6.25接收,第二篇sci,共勉!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66548632914, createdName=ms4000000480569699, createdTime=Tue Jul 02 14:33:27 CST 2024, time=2024-07-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=998056, encodeId=d8f0998056a3, content=2020年10月31号投稿,2021年1月14日返修,2月25日修回,2月27日显示送外审,到现在状态也没变化,时间也没变化,有没有类似情况的朋友?已经4个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ceb5420687, createdName=ms6000001352468085, createdTime=Fri Jul 09 20:11:44 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205846, encodeId=869e1205846dc, content=请问大家irb approval怎么搞的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/GVenxYicdvic8y0S8u0eCicFMiaY4MhYKianWnHAOEhmrUuIG95l4TY9VHliaG0SHOtNeXQia1WYGhhYMSzHcDlaz4WBA/132, createdBy=e3105157968, createdName=pmzhangjie, createdTime=Fri Mar 25 13:42:05 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2168342, encodeId=0a6c2168342a4, content=审稿速度:1.0<br>偏重的研究方向:生殖医学<br>经验分享:有大佬知道 Change authorship form在哪儿嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2c38649666, createdName=ms7000000322607475, createdTime=Mon Nov 13 21:54:09 CST 2023, time=2023-11-13, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1083380, encodeId=813c108338041, content=偏重的研究方向:生物信息学;围产医学;生殖医学<br>经验分享:请问上传伦理审查的文件在哪里找,提交需要IRB approval,是自己写完找单位盖章吗,求各位大神 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=996d5652385, createdName=ms3000002068420902, createdTime=Thu Dec 23 00:22:15 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569900, encodeId=32645699002b, content=online快一年了,还没有正式出版没有卷和期号无法进行文献检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/848cb2649bb2ba3563871a6dd0e8c5e7.jpg, createdBy=45362264868, createdName=打豆豆d d d, createdTime=Mon Apr 22 00:00:00 CST 2019, time=2019-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222142, encodeId=0089122214274, content=大修返修回去之后一直是Editor Assigned状态,有人知道什么意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/01/5ff3f1f23a551b430a9b118ce34c50e5.jpg, createdBy=fe362272136, createdName=Coolina-, createdTime=Tue May 24 19:32:08 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209829, encodeId=a66f120982933, content=大家的参考文献格式用的哪种哇?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50e56410073, createdName=ms7000000685176097, createdTime=Sat Apr 09 16:13:55 CST 2022, time=2022-04-09, status=1, ipAttribution=)]
    2022-04-09 ms7000000685176097

    大家的参考文献格式用的哪种哇?

    1

    展开1条回复
共134条页码: 1/14页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map